A study of lipoprotein (a) and biochemical parameters of metabolic syndrome among younger population

B Poonguzhali; J Sowndharya; Thivyah Prabha; K Suganya

doi:10.53730/ijhs.v6nS1.8721

Authors

Poonguzhali. B
nesihaguzhali@gmail.com
Senior Assistant Professor, Department of Biochemistry, Government Karur Medical College & Hospital, Karur, Tamilnadu, India
Sowndharya. J Senior Assistant Professor, Department of Biochemistry, Government Karur Medical College & Hospital, Karur, Tamilnadu, India
Thivyah Prabha Associate Professor, Department of Biochemistry, St.Peters Medical College Hospital & Research Institute, Hosur Tamilnadu, India
Suganya. K Assistant professor, Department of Physiology, SRMC & RI, SRIHER, Porur, Chennai, Tamilnadu, India

Keywords:

Metabolic syndrome, Lipoprotien (a), HDL-cholesterol, triglycerides, fasting glucose

Abstract

Metabolic syndrome is a cluster of conditions that occur together, increasing your risk of heart disease, stroke and type 2 diabetes. Aim & Objective: Due to the scarcity of studies about the epidemiological behaviour of Lp(a) in our country, the main aim of our research is to study the relationship between Lp(a) and the metabolic syndrome and its components in younger population Materials & Methods: A total of 136 subjects were enrolled into the study. A pre-structured and pretested proforma was used to collect the data. Baseline data including age, gender, religion, detailed medical history, clinical examinations and relevant investigations such as HDL-cholesterol, triglyceride, lipoprotein (a) and fasting glucose were done in the study. Analysis was done by SPSS version 18. In our study, 46.2% males and 43.1% females were affected by metabolic syndrome with no significant correlation with sex. Lipoprotein (a) level is increased in the metabolic syndrome category by Modified NCEP ATP III Criteria and IDF Criteria. Lipoprotein (a) level has significant correlation with the metabolic syndrome according to their p values (<0.01). It has significantly correlated with the individual components of metabolic syndrome and age category too (p value <0.01).

Downloads

Download data is not yet available.

References

Borch-Johnsen K. The metabolic syndrome in a global perspective. Dan

Med Bull.2007;54:157-9.

Enas EA,Mohan V,Deepa M,Farooq S,Pazhoor S and Chennikara H.The metabolic syndrome and dyslipidemia among asian indians: a population with high rates of diabetes and premature coronary artery disease. J cardio metab syndr. 2007;2(4):267-75.

Ashfaq F, Goel PK,Sethi R,Khan MI, Ali W, Idris MZ.Lipoprotein (a) levels in relation to severity of coronary artery disease in North Indian patients. Heart views. 2013; 14:12-6.

Bermudez V, Rojas J, Salazar J,Bello L, Anez R, Toledo A et al. Variations of Lipoprotein (a) levels in the Metabolic syndrome: A Report from the Maracaibo city Metabolic syndrome Prevalence study. J Dia Res.2013:1-12.

Ballantyne CM, Olsson AG, Cook TJ, Mercuri MF, Pedersen TR, Kjekshus J.Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4s.Circulation.2001; 104:3046-51.

Nesto R.C-reactive protein, its role in inflammation, type 2 diabetes and cardiovascular disease, and the effects of insulin sensitizing treatment with thiazolidinediones. Dia Med.2004; 21:810-17.

Murakami T,Michelagnoli S,Longi R.Triglycerides are major determinants of cholesterol esterfication / transfer and HDL remodelling in human plasma. Arterioscler Thromb Vasc Biol. 1995; 15:1819-28.

Brinton EA, Eisenberg S, Breslow JL.Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein cholesterol levels with or without hypertriglyeridemia. J Clin Invest. 1991; 87(2):536-44.

Misra A, Misra R, Wijesuriya M, Banerjee D. The metabolic syndrome in south Asians:Continuing escalation & possible solutions. Indian J Med Res.2007;125:345-54.

Gupta R, Deedwania PC, Gupta A, Rastogi S, Panwar RB, Kothari K. Prevalence of metabolic syndrome in an Indian urban population. Int J Cardiol. 2004;97(2):257-61.

Gu D, Reynolds K, Wu X, Chen J, Duan X, Reynolds RF, Whelton PK, He J; InterASIA Collaborative Group. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet. 2005; 365(9468):1398-405.

Vinodh PB, Ambekar JG, Havilah P.Metabolic syndrome among adult individuals- A preliminary cross sectional study in Kurnool district. Intern J Chem Life Sci. 2013;2 (5): 1168- 71.

Ramachandran A, Snehalatha C, Satyavani K, Sivasankari S, Vijay V.Metabolic syndrome in urban Asian Indian adults--a population study using modified ATP III criteria. Diabetes Res Clin Pract. 2003;60(3):199-204.

Parale GP, Patil VC, Patil SP, Sabale SV, Pethe CV, Manjunath GS, Kulkarni PM, Dhadke VN, Deshpande NS. Metabolic syndrome in railway employees and its relation to lifestyle factors. Metab Syndr Relat Disord. 2008;6(1):58-63.

Sarkar S, Das M, Mukhopadhyay B, Chakrabarti CS, Majumder PP. High prevalence of metabolic syndrome & its correlates in two tribal populations of India & the impact of urbanization. Indian J Med Res.2006;123:679-86.

Shahbazian H, Latifi SM, Jalali MT, Amani R, Nikoo A, Aleali AM et al.Metabolic syndrome and its correlated factors in an urban population in South West of Iran.J Dia Metab Disord.2013;12(11):1-6.

Kamble P, Deshmukh PR , Garg N. Metabolic syndrome in adult population of rural Wardha, central India. Ind J Med Res. 2010; 132: 701- 5.

Surana SP, Shah DB, Gala K, Susheja S, Hoskote SS, Joshi SR et al. Prevalence of Metabolic syndrome in an urban Indian diabetic population using the NCEP ATP III guidelines. JAPI. 2008; 56:865-8.

Shahbazian H, Latifi SM, Jalali MT, Amani R, Nikoo A, Aleali AM et al.Metabolic syndrome and its correlated factors in an urban population in South West of Iran.J Dia Metab Disord.2013;12(11):1-6.

Bermudez V, Rojas J, Salazar J, Bello L, Anez R, Toledo A et al. Variations of Lipoprotein(a) levels in the metabolic syndrome: A report from the Maracaibo City metabolic syndrome prevalence study. J Dia Res;2013:1-12.

Bozbas H, Yildirir A, Pirat B. Increased lipoprotein (a) in metabolic syndrome: is it a contributing factor to premature atherosclerosis? Anadol Kardiyol Derg. 2008; 8(2):111–15

Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2022). Post-pandemic health and its sustainability: Educational situation. International Journal of Health Sciences, 6(1), i-v. https://doi.org/10.53730/ijhs.v6n1.5949

Kotani K, Shimohiro H, Adachi S, Sakane N. Relationship between lipoprotein(a), metabolic syndrome, and carotid atherosclerosis in older Japanese people. Gerontol. 2008; 54(6):361–4.

Konerman M, Kulkarni K, Toth PP, Jones SR. Evidence of dependence of lipoprotein(a) on triglyceride and highdensity lipoprotein metabolism. J Clin Lipid. 2012; 6(1):27-32.

Cˆandido AP, Ferreira S, Lima AA. Lipoprotein(a) as a risk factor associated with ischemic heart disease: ouro preto study. Atherosclerosis. 2007; 191(2): 45445–49.

Slunga L, Asplund K, Johnson O, Dahlen GH. Lipoprotein(a) in a randomly selected 25-64 year old population: the Northern Sweden Monica study. J Clin Epidemiol. 1993;46(7):617–24.

Chien KL, Lee YT, Sung FC, Su TC, Hsu HC, Lin RS. Lipoprotein (a) level in the population in Taiwan: relationship to socio demographic and atherosclerotic risk factors. Atherosclerosis.1999; 143(2): 267–73.